Observational Study of Patients With Subarachnoid Hemorrhage
ProReSHA
A Prospective, Observational Registry of Patient With Subarachnoid Hemorrhage in Neurocritical Care Unit
1 other identifier
observational
1,000
1 country
1
Brief Summary
This prospective, observational study aim to identify :
- Prognostic factor of patients with subarachnoid haemorrhage in neuro intensive care unit
- The impact of standard therapeutic used (surgery, embolization ; medical treatment of vasospasm ; treatment of complications like hyponatremia, stress myocardiopathy, …)
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2017
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 24, 2016
CompletedFirst Posted
Study publicly available on registry
September 7, 2016
CompletedStudy Start
First participant enrolled
February 16, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 16, 2020
CompletedFebruary 23, 2018
February 1, 2018
3.1 years
August 24, 2016
February 22, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Survival
at day 0
Survival
at 6 months
Survival
at 12 months
Secondary Outcomes (10)
Neurological outcome with the Glasgow Coma Scale (GCS) score
at day 0
Neurological outcome with the Glasgow Coma Scale (GCS) score
at 6 months
Neurological outcome with the Glasgow Coma Scale (GCS) score
at 12 months
Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score
at day 0
Neuropsychological outcome with the Montreal Cognitive Assessment (MoCA) score
at 6 months
- +5 more secondary outcomes
Eligibility Criteria
All patients admitted to the unit of investigator with subarachnoid hemorrhage, whatever the etiology, is included in their prospective registry
You may qualify if:
- Subarachnoid hemorrhage
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Service de réanimation polyvalente neurologique Hôpital Neurologique HCL
Bron, 69500, France
Related Publications (1)
Chardon N, Nourredine M, Ledochowski S, Kurland NT, Dailler F, Ritzenthaler T, Nougier C, Balanca B. Trajectory of mean platelet volume changes after aneurysmal subarachnoid hemorrhage in patients with or without delayed cerebral ischemia. Sci Rep. 2024 Oct 24;14(1):25122. doi: 10.1038/s41598-024-75587-8.
PMID: 39448701DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Frédéric DAILLER, MD
Service de réanimation neurologique Hospices Civils de Lyon
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 24, 2016
First Posted
September 7, 2016
Study Start
February 16, 2017
Primary Completion
March 16, 2020
Study Completion
March 16, 2020
Last Updated
February 23, 2018
Record last verified: 2018-02
Data Sharing
- IPD Sharing
- Will not share